Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia
International Journal of Molecular Sciences · 01.05.2023 · 24 (9) · 8117
DOI: 10.3390/ijms24098117 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.05.2023. Verfasst von Hanan Ehtewish und 21 weiteren Autor:innen. Beteiligte Einrichtung: College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar National Research Fund, QBRI Interdisciplinary Research Program, College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation.
Themen: Demenz
Abstract (Originalsprache)
Dementia is a progressive and debilitating neurological disease that affects millions of people worldwide. Identifying the minimally invasive biomarkers associated with dementia that could provide insights into the disease pathogenesis, improve early diagnosis, and facilitate the development of effective treatments is pressing. Proteomic studies have emerged as a promising approach for identifying the protein biomarkers associated with dementia. This pilot study aimed to investigate the plasma proteome profile and identify a panel of various protein biomarkers for dementia. We used a high-throughput proximity extension immunoassay to quantify 1090 proteins in 122 participants (22 with dementia, 64 with mild cognitive impairment (MCI), and 36 controls with normal cognitive function). Limma-based differential expression analysis reported the dysregulation of 61 proteins in the plasma of those with dementia compared with controls, and machine learning algorithms identified 17 stable diagnostic biomarkers that differentiated individuals with AUC = 0.98 ± 0.02. There was also the dysregulation of 153 plasma proteins in individuals with dementia compared with those with MCI, and machine learning algorithms identified 8 biomarkers that classified dementia from MCI with an AUC of 0.87 ± 0.07. Moreover, multiple proteins selected in both diagnostic panels such as NEFL, IL17D, WNT9A, and PGF were negatively correlated with cognitive performance, with a correlation coefficient (r2) ≤ −0.47. Gene Ontology (GO) and pathway analysis of dementia-associated proteins implicated immune response, vascular injury, and extracellular matrix organization pathways in dementia pathogenesis. In conclusion, the combination of high-throughput proteomics and machine learning enabled us to identify a blood-based protein signature capable of potentially differentiating dementia from MCI and cognitively normal controls. Further research is required to validate these biomarkers and investigate the potential underlying mechanisms for the development of dementia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
- Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
- Department of Medicine, Weill Cornell Medicine-Qatar, Qatar Foundation (QF), Doha P.O. Box 24144, Qatar.
- Diabetes Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
- The Neuroscience Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha P.O. Box 3050, Qatar.
- Proteomics Core Facility, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
ORCID-Profile: Hanan Ehtewish, Areej Mesleh, Alberto De la Fuente, Raheem Ayadathil, Ahmed Elsotouhy, Essam M Abdelalim, Julie Decock, Nehad M Alajez, Omar Albagha, Paul J Thornalley, Abdelilah Arredouani, Rayaz A Malik, Omar M A El-Agnaf
Förderung
- Qatar National Research Fund
- QBRI Interdisciplinary Research Program
- College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Zitieren
APA
Ehtewish, H., Mesleh, A., Ponirakis, G., De la Fuente, A., Parray, A., Bensmail, I., Abdesselem, H., Ramadan, M., Khan, S., Chandran, M., Ayadathil, R., Elsotouhy, A., Own, A., Al Hamad, H., Abdelalim, E. M., Decock, J., Alajez, N. M., Albagha, O., Thornalley, P. J., …, & El-Agnaf, O. M. A. (2023). Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia. International Journal of Molecular Sciences, 24(9), 8117. https://doi.org/10.3390/ijms24098117
Vancouver
Ehtewish H, Mesleh A, Ponirakis G, De la Fuente A, Parray A, Bensmail I, et al. Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia. International Journal of Molecular Sciences. 2023;24(9):8117. doi:10.3390/ijms24098117
BibTeX
@article{Ehtewish2023,
author = {Ehtewish, Hanan and Mesleh, Areej and Ponirakis, Georgios and De la Fuente, Alberto and Parray, Aijaz and Bensmail, Ilham and Abdesselem, Houari and Ramadan, Marwan and Khan, Shafi and Chandran, Mani and Ayadathil, Raheem and Elsotouhy, Ahmed and Own, Ahmed and Al Hamad, Hanadi and Abdelalim, Essam M and Decock, Julie and Alajez, Nehad M and Albagha, Omar and Thornalley, Paul J and Arredouani, Abdelilah and Malik, Rayaz A and El-Agnaf, Omar M A},
title = {Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {9},
pages = {8117},
doi = {10.3390/ijms24098117}
}
EUVIMED